Skip to main content
. Author manuscript; available in PMC: 2011 Aug 4.
Published in final edited form as: Aliment Pharmacol Ther. 2010 Mar 26;32(1):29–42. doi: 10.1111/j.1365-2036.2010.04315.x

Figure 4.

Figure 4

Placebo response rates in trials using proton pump inhibitors versus trials using H2-receptor antagonists. The placebo response rate among patients receiving PPI therapy was borderline significantly lower than the response rate among patients taking H2-receptor antagonists (14.5% vs. 24.7%, respectively; p =0.05).